For: | deLemos AS, Schmeltzer PA, Russo MW. Recurrent hepatitis C after liver transplant. World J Gastroenterol 2014; 20(31): 10668-10681 [PMID: 25152571 DOI: 10.3748/wjg.v20.i31.10668] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v20/i31/10668.htm |
Number | Citing Articles |
1 |
Danielle Detelich, James F. Markmann. Normothermic liver preservation, current status and future directions. Current Opinion in Organ Transplantation 2018; 23(3): 347 doi: 10.1097/MOT.0000000000000531
|
2 |
|
3 |
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1
|
4 |
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2017; : 355 doi: 10.1007/978-3-319-07209-8_21
|
5 |
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
|
6 |
Anne M. Larson, George B. McDonald. Transplant Infections. 2016; : 653 doi: 10.1007/978-3-319-28797-3_36
|
7 |
H. Imai, H. Kamei, Y. Onishi, Y. Ishizu, M. Ishigami, H. Goto, Y. Ogura. Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus. Transplantation Proceedings 2018; 50(5): 1431 doi: 10.1016/j.transproceed.2018.03.005
|
8 |
Marcos Mucenic, Ajacio Bandeira de Melo Brandão, Claudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Maria Lucia Zanotelli, Ian Leipnitz, Mário Henrique Meine, Guillermo Kiss, Juliano Martini, Eduardo Soares Schlindwein, Ane Micheli Costabeber, Fernanda Karlinsky Rodrigues Sacco, Giovana Rossato, Guido Pio Cracco Cantisani. Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review. Revista do Instituto de Medicina Tropical de São Paulo 2019; 61 doi: 10.1590/s1678-9946201961012
|
9 |
Dina M. Ahmed, Mona R. Abd-Alaziz, Ibrahim M. Ibrahim, Naglaa A. El-gendy. Retrospective study of the outcome of liver transplantation in Egyptian patients with chronic hepatitis C virus infection. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2020; 4(4): 631 doi: 10.4103/sjamf.sjamf_84_20
|
10 |
M. Mucenic, A. Bandeira de Mello Brandao, C.A. Marroni, A. Medeiros Fleck, M.L. Zanotelli, G. Kiss, M.H. Meine, I. Leipnitz, E. Soares Schlindwein, J. Martini, A.M. Costabeber, F.K.F. Sacco, G.P. Cracco Cantisani. Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study. Transplantation Proceedings 2018; 50(3): 769 doi: 10.1016/j.transproceed.2018.02.001
|
11 |
Alice C. Huang, Angela Beadles, Danielle Romero, William Berquist, Rachel Bensen, Paul Kwo, Rebecca B. Mckenzie. Sustained Virologic Remission in an 8‐Month‐old Pediatric Patient With Carbamoyl Phosphate Synthetase I Deficiency and Hepatitis C Infection Using Direct‐acting Antivirals Prior to Liver Transplant. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(3) doi: 10.1097/MPG.0000000000002856
|
12 |
|
13 |
M. Bodro, G. Sanclemente, G. Crespo, L. Linares, M.A. Marcos, F. Marco, R. Miquel, X. Forns, M. Navasa, A. Moreno. Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients. Transplantation Proceedings 2018; 50(5): 1437 doi: 10.1016/j.transproceed.2018.02.081
|